LRRK2 and Parkinson disease: These results suggest that, once active, the LRRK2 kinase phosphorylates α-Syn at Ser129 (Qing et al. 2009), which is the major component of pathological deposits in PD (Fujiwara et al. 2002; Du et al. 2021).